PTGS2 and breast carcinoma in situ: The two studies of normal breast epithelium included in our review provided very different estimates of the prevalence of COX-2 expression in normal tissue, so we cannot determine whether COX-2 expression occurs more or less frequently in invasive or in-situ breast cancer than in normal breast tissue.